TTM
$1.89B
YoY change
-114.0%
5Y CAGR
—
Peak year (2022)
$6.43B
Cumulative EBITDA
$41.72B
EBITDA history chart for Viatris (VTRS) from 2003 to 2025
Latest: −$395.40M
EBITDA growth chart for Viatris (VTRS) from 2003 to 2025
Latest: -114.0%
EBITDA history table for Viatris (VTRS) from 2003 to 2025
| 2025 | −$395.40M | -114.0% | −$3.22B | ||
| 2024 | $2.82B | -19.8% | −$696.50M | ||
| 2023 | $3.52B | -45.3% | −$2.92B | ||
| 2022 | $6.43B | +43.7% | +$1.95B | ||
| 2021 | $4.48B | +124.7% | +$2.49B | ||
| 2020 | $1.99B | -25.9% | −$698.30M | ||
| 2019 | $2.69B | -8.8% | −$259.60M | ||
| 2018 | $2.95B | -9.0% | −$292.80M | ||
| 2017 | $3.24B | +54.5% | +$1.14B | ||
| 2016 | $2.10B | -8.2% | −$187.40M | ||
| 2015 | $2.29B | +22.0% | +$412.60M | ||
| 2014 | $1.87B | +18.9% | +$297.70M | ||
| 2013 | $1.58B | -5.0% | −$82.90M | ||
| 2012 | $1.66B | +10.5% | +$158.23M | ||
| 2011 | $1.50B | +35.2% | +$391.07M | ||
| 2010 | $1.11B | +17.3% | +$163.57M | ||
| 2009 | $946.63M | +28.9% | +$212.13M | ||
| 2008 | $734.50M | -174.1% | +$1.73B | ||
| 2007 | −$991.80M | — | — | ||
| 2005 | $334.21M | -3.8% | −$13.06M | ||
| 2004 | $347.27M | -35.6% | −$191.85M | ||
| 2003 | $539.12M | — | — |
- 2025−$395.40M-114.0%
- 2024$2.82B-19.8%
- 2023$3.52B-45.3%
- 2022$6.43B+43.7%
- 2021$4.48B+124.7%
- 2020$1.99B-25.9%
- 2019$2.69B-8.8%
- 2018$2.95B-9.0%
- 2017$3.24B+54.5%
- 2016$2.10B-8.2%
- 2015$2.29B+22.0%
- 2014$1.87B+18.9%
- 2013$1.58B-5.0%
- 2012$1.66B+10.5%
- 2011$1.50B+35.2%
- 2010$1.11B+17.3%
- 2009$946.63M+28.9%
- 2008$734.50M-174.1%
- 2007−$991.80M—
- 2005$334.21M-3.8%
- 2004$347.27M-35.6%
- 2003$539.12M—
EBITDA values are taken from Viatris's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About EBITDA at Viatris (VTRS)
According to Viatris's latest reported financial statements, the company's current EBITDA (TTM) is $1.89B. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a common proxy for operating cash generation that strips out non-cash charges (depreciation and amortization) and capital structure effects (interest, taxes). Useful for comparing companies with different leverage and asset bases — see operating income and net income for fully GAAP figures.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
In 2025, Viatris (VTRS) EBITDA totalled −$395.40M – plunged 114.0% year-over-year.
Between 2022 and 2025, Viatris EBITDA plunged 106.1%, falling from $6.43B to −$395.40M.
2022 marks the peak EBITDA at $6.43B, with the historical low of −$991.80M recorded in 2007.
Viatris EBITDA by Year
Viatris EBITDA 2025: −$395.40M
Viatris EBITDA in 2025 was −$395.40M, plunged 114.0% below 2024.
Viatris EBITDA 2024: $2.82B
2024's EBITDA for Viatris came in at $2.82B, declined 19.8% below 2023.
Viatris EBITDA 2023: $3.52B
Viatris posted EBITDA of $3.52B in 2023, plunged 45.3% below 2022.
Viatris EBITDA 2022: $6.43B
In 2022, Viatris reported EBITDA of $6.43B, surged 43.7% from 2021. This figure represents the highest annual value in the available history.
Viatris EBITDA 2021: $4.48B
Viatris EBITDA in 2021 was $4.48B.
See more financial history for Viatris (VTRS).
Sector peers by EBITDA
Healthcare peers of Viatris (VTRS), ranked by their latest EBITDA
| $41.05B | |
| $28.26B | |
| $27.94B | |
| $24.43B | |
| $23.06B | |
| $19.83B | |
| $17.63B | |
| $16.90B |
- $41.05B
- $28.26B
- $27.94B
- $24.43B
- $23.06B
- $19.83B
- $17.63B
- $16.90B
Frequently asked questions
Viatris (VTRS) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation